HOLLI PERRY: Open Payments
NPI 1689172132 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,425 in 66 payments from 12 companies in 2025. Trend: 2023 $1,272 · 2024 $976 · 2025 $1,425
Food & beverage: $1,425
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 20 | $398 |
| ABBVIE INC. | 10 | $220 |
| Incyte Corporation | 7 | $195 |
| UCB, Inc. | 7 | $185 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $136 |
| Novartis Pharmaceuticals Corporation | 6 | $120 |
| Janssen Biotech, Inc. | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| SpringWorks Therapeutics, Inc. | 1 | $27 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
Products named: Zoryve, OPZELURA, Bimzelx, RINVOQ, COSENTYX, TREMFYA, SKYRIZI, LIBTAYO.
Industry payments across TX — which companies pay providers there.
